XML 52 R40.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 6 - Stockholders' Deficit (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Notes Tables    
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Expected dividend yield
 
0%
 
Risk free interest rate
  1.01%
-
2.43%
Expected life in years
 
5
 
Expected volatility 
  85%
-
213%
 
 
2015
 
2014
 
Expected dividend yield
 
 
 0%
 
 
 
 0
%
Risk free interest rate
 
 1.66%
-
2.43% 
 
 
 2.30
%
Expected life in years
 
 
10
 
 
 
10
 
Expected volatility
 
 
85%
 
 
 
85
%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
 
 
 
 
 
 
Exercise
 
 
Weighted Average
 
 
 
Number
 
 
Price
 
 
Exercise Price
 
Stock Options
 
 
 
 
 
 
 
 
 
 
 
 
                         
Outstanding January 1, 2016
   
1,707,744
     
 
    $
0.84
 
Granted
   
1,301,084
    $
1.25
     
 
 
Expired
   
(416,599
)    
 
     
 
 
Outstanding September 30, 2016
   
2,592,229
     
 
    $
1.04
 
 
 
 
 
 
 
Exercise
 
 
Weighted
Average
 
 
 
Number
 
 
Price
 
 
Exercise Price
 
Stock Options
 
 
 
 
 
 
 
 
 
 
 
 
                         
Outstanding January 1, 2014
   
977,744
     
 
    $
0.60
 
Granted
   
240,000
    $
1.00
     
 
 
Outstanding December, 31, 2014
   
1,217,744
     
 
    $
0.68
 
Granted
   
490,000
    $
1.25
     
 
 
Outstanding December, 31, 2015
   
1,707,744
     
 
    $
0.84
 
Schedule of Nonvested Share Activity [Table Text Block]  
Number
of
Options
       Expiration
Date
 
Remaining
Contractual Life
(Years)
 
 
Exercise
Price
 
104,150  
March 1, 2016
   
0.17
    $
0.26
 
312,449  
March 15, 2016
   
0.21
    $
0.26
 
55,000  
August 1, 2016
   
0.59
    $
0.26
 
60,000  
November 1, 2016
   
0.84
    $
0.26
 
21,145  
February 1, 2017
   
1.09
    $
1.00
 
290,000  
March 1, 2021
   
5.25
    $
1.00
 
10,000  
June 10, 2021
   
5.45
    $
1.00
 
50,000  
April 1, 2022
   
6.25
    $
1.00
 
75,000  
December 1, 2022
   
6.92
    $
1.00
 
90,000  
March 1, 2024
   
8.17
    $
1.00
 
215,000  
March 1, 2025
   
9.17
    $
1.25
 
75,000  
March 9, 2025
   
9.19
    $
1.25
 
150,000  
March 1, 2027
   
11.17
    $
1.00
 
200,000  
January 22, 2030
   
14.07
    $
1.25
 
1,707,744                    
Schedule of Warrants Outstanding [Table Text Block]  
 
 
December
31,
2015
 
 
December
31,
2014
 
Financing and stock subscriptions (includes
300,000 warrants to the Major Stockholder and
Chairman)
   
2,100,000
     
2,100,000
 
Consultants
   
350,000
     
100,000
 
Major Stockholder and Chairman
   
953,367
     
953,367
 
Total Warrants Issued
   
3,403,367
     
3,153,367
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
 
 
 
 
 
 
Exercise
 
 
Weighted Average
 
 
 
Number
 
 
Price
 
 
Exercise Price
 
Warrants
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding January 1, 2016
   
3,403,367
     
 
    $
1.05
 
Granted
   
423,291
    $
1.25
     
 
 
Outstanding September 30, 2016
   
3,826,658
     
 
    $
1.07
 
 
 
 
 
 
 
Exercise
 
 
Weighted
Average
 
 
 
Number
 
 
Price
 
 
Exercise Price
 
Warrants
 
 
 
 
 
 
 
 
 
 
 
 
                         
Outstanding January 1, 2014
   
3,153,367
     
 
    $
1.01
 
Granted
   
-
    $
-
     
 
 
Outstanding December, 31, 2014
   
3,153,367
     
 
    $
1.00
 
Granted
   
250,000
    $
1.25
     
 
 
Outstanding December, 31, 2015
   
3,403,367
     
 
    $
1.05
 
By Expiration Date [Member]    
Notes Tables    
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]  
Number of
Common Stock
Equivalents
 
Expiration
Date
 
Remaining Contractual
Life(Years)
 
Exercise Price
 
100,000  
01/01/2017
 
 
1.2
 
  $
1.25
 
675,000  
07/07/2021
 
 5.5
to
6.7 
  $
1.00
 
2,628,367  
12/20/2023
 
 7.3
to
8.1
  $
1.05
 
3,403,367